Technical Analysis for NUVA - NuVasive, Inc.

Grade Last Price % Change Price Change
grade A 74.75 1.33% 0.98
NUVA closed up 1.33 percent on Friday, December 6, 2019, on 68 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NUVA trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
New 52 Week High Strength 0.00%
Stochastic Reached Overbought Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Older signals for NUVA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine. The company's products focus on applications for spine fusion surgery. It offers products for the thoracolumbar spine and the cervical spine primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company's principal products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines three categories of product offerings, including NVM5 and NVJJB, its proprietary software-driven nerve detection and avoidance systems, and intra-operative monitoring support services for insight into the nervous system during spine and other surgeries; MaXcess, an integrated split-blade retractor system; and various specialized implants. The company's biologic products include allograft, a donated human tissue; FormaGraft, a collagen synthetic product; Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells; and AttraX, a synthetic bone graft material. It also offers solutions for cervical fusion surgery, including allograft and CoRoent implants, as well as cervical plating and posterior fixation products. In addition, the company's products comprise PCM device, a motion preserving total disc replacement device; and XL TDR, a mechanical total disc replacement solution. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Medicine Surgery Stem Cells Neurosurgery Transplantation Medicine Biologic Products Spinal Fusion Surgeries Allotransplantation Bone Grafting Neurosurgical Procedures Intervertebral Disc Arthroplasty

Is NUVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 75.07
52 Week Low 43.51
Average Volume 496,823
200-Day Moving Average 62.23
50-Day Moving Average 68.53
20-Day Moving Average 72.56
10-Day Moving Average 72.85
Average True Range 1.48
ADX 35.78
+DI 26.32
-DI 9.72
Chandelier Exit (Long, 3 ATRs ) 70.63
Chandelier Exit (Short, 3 ATRs ) 75.16
Upper Bollinger Band 74.20
Lower Bollinger Band 70.91
Percent B (%b) 1.17
BandWidth 4.53
MACD Line 1.32
MACD Signal Line 1.33
MACD Histogram -0.0179
Fundamentals Value
Market Cap 3.8 Billion
Num Shares 50.8 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 118.65
Price-to-Sales 2.91
Price-to-Book 4.32
PEG Ratio 2.15
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 76.37
Resistance 3 (R3) 76.30 75.68 76.10
Resistance 2 (R2) 75.68 75.27 75.72 76.01
Resistance 1 (R1) 75.22 75.02 75.45 75.29 75.92
Pivot Point 74.60 74.60 74.72 74.64 74.60
Support 1 (S1) 74.14 74.19 74.37 74.21 73.58
Support 2 (S2) 73.52 73.94 73.56 73.49
Support 3 (S3) 73.06 73.52 73.40
Support 4 (S4) 73.13